Motus GI Holdings, Inc. (MOTS): Business Model Canvas [Apr-2026 Updated]

You're looking at the final chapter for Motus GI Holdings, Inc. (MOTS), a classic medtech story that ended not with a bang, but with a Chapter 11 wind-down after selling the core Pure-Vu System asset to CONMED for roughly $14 million. Forget growth projections; the current business model is purely administrative, focused on settling claims while the public shell trades for pennies-we're talking a market cap near $719.09 as of late 2025. If you need to understand the mechanics of a corporate dissolution or track the final distributions to creditors and shareholders, the full Business Model Canvas below maps out this stark, final reality for MOTS.

Motus GI Holdings, Inc. (MOTS) - Canvas Business Model: Key Partnerships

You're looking at the final structure of partnerships for Motus GI Holdings, Inc. (MOTS), which, honestly, is now a historical footnote, as the company ceased independent operations following a Chapter 7 bankruptcy filing in May 2024. The key relationships are defined by the asset sale that concluded the entity.

Key Partnerships

The partnership structure centers on the acquisition of the core technology and the necessary professional services to manage the wind-down. The company's ability to execute on its commercial strategy was entirely dependent on these external relationships.

• Legal and financial advisors managing the Chapter 7 liquidation process.
• CONMED Corporation, the acquirer of the Pure-Vu System asset.
• Creditors and debt holders for settling outstanding claims and liabilities.
• Regulatory bodies like the SEC for public company compliance during liquidation.

The most significant partnership, or rather, the final transaction, involved the sale of the Pure-Vu System assets. This was the ultimate exit for the technology, moving it from a struggling independent entity to a major player's portfolio.

The relationships with financial and legal teams were critical for navigating the insolvency. While the specific law firms and restructuring advisors for the May 2024 Chapter 7 filing aren't explicitly detailed in the latest filings available, the financial advisory relationship leading up to the collapse provides context on who was involved in capital structure management.

Here's the quick math on the financial advisory context: A.G.P./Alliance Global Partners advised on a transaction in February 2024 that brought in approximately $2.7 million in gross proceeds, which was a last-ditch effort before the asset sale.

The relationship with creditors and debt holders, including those under the prior Loan and Security Agreement with Silicon Valley Bank, was managed through the bankruptcy court process to settle claims against the remaining estate following the asset sale. The final disposition of these liabilities was directly tied to the $14 million received from CONMED Corporation.

For regulatory oversight, the Securities and Exchange Commission (SEC) remained a key partner, even in liquidation. The SEC oversees the final disclosures, including Form 15 filings to terminate registration requirements for public companies, which is a necessary step after an asset sale and bankruptcy to manage final compliance obligations.

The technology's clinical validation, while not a partnership in the traditional sense, was a critical external validation point: the Pure-Vu System showed visualization improvement from a baseline of 38% to 96% in clinical studies. That's the value CONMED acquired.

Finance: review the final creditor distribution schedule from the bankruptcy trustee by next Tuesday.

Motus GI Holdings, Inc. (MOTS) - Canvas Business Model: Key Activities

You're looking at the final phase of a company's life cycle, so the Key Activities for Motus GI Holdings, Inc. as of late 2025 are entirely focused on cessation, not growth. Honestly, the core business-the development and commercialization of the Pure-Vu® System-ended when its assets were acquired by CONMED Corporation in early 2024. The activities now are purely administrative and financial closure.

Liquidating remaining non-core assets and intellectual property.

The most significant IP, the Pure-Vu System technology, was already sold to CONMED Corporation for approximately $14 million in Q1 2024. This means the current activity centers on any residual, non-core assets. Since the company is effectively a shell, the value of these remaining assets is reflected in the market capitalization as of December 4, 2025, which stood at $719. The activity involves cataloging, valuing, and disposing of these final items.

• Finalizing disposition of any remaining office equipment or minor IP rights.
• Processing any residual accounts receivable not transferred in the asset sale.
• Reporting final asset values to the sole director.

Managing the ongoing legal and administrative requirements of a public shell company.

This is the bulk of the work now, managed by the sole director, Jeff Varsalone, following the resignation of the prior executive team in July 2024. The company must maintain its public status to facilitate the final distribution of any remaining cash to creditors and shareholders, a process that requires adherence to SEC rules for a non-operating entity. The company's reporting structure is simplified, but compliance costs persist.

Here's a look at the financial context leading into this wind-down phase:

Settling remaining debt obligations and creditor claims.

A major trigger for the current state was the Notice of Default received from Kreos Capital VI (Expert Fund) LP on June 17, 2024, which stemmed from the board's approved plan of distribution on June 6, 2024. This means the primary financial activity is managing the claims process under the terms dictated by that default and the bankruptcy proceedings. You're dealing with the final settlement amounts for secured and unsecured creditors.

• Negotiating final settlement figures with Kreos Capital VI.
• Processing claims filed by vendors and former employees.
• Distributing funds according to the priority established in the wind-down plan.

Executing the final business wind-down plan approved by the board.

The activity is the methodical execution of the plan that was approved in mid-2024. This is a time-bound process designed to conclude the corporate existence of Motus GI Holdings, Inc. The focus is on minimizing administrative overhead while maximizing the recovery for stakeholders based on the $14 million asset sale proceeds. The company's prior revenue performance, such as the $327.00k in revenue reported before the final operational shift, is now irrelevant; the focus is on the final cash balance.

Finance: draft final cash reconciliation report by next Tuesday.

Motus GI Holdings, Inc. (MOTS) - Canvas Business Model: Key Resources

You're looking at the absolute bare bones of what's left for Motus GI Holdings, Inc. (MOTS) as it winds down operations in late 2025. The key resources aren't about growth anymore; they are about managing the cessation of business and fulfilling remaining obligations. It's a very different picture than when the company was commercializing the Pure-Vu System.

The primary financial resource stems directly from the 2024 asset disposition. The core asset, the Pure-Vu System technology, was sold to CONMED Corporation for approximately $14 million following the bankruptcy filing in early 2024. The remaining cash and equivalents figure as of late 2025 is the residual balance from this sale and any prior operations, which is not explicitly itemized in the latest public data but is the sole source of liquidity for administrative closure.

The public listing itself remains a resource, albeit one with severely diminished market value. The company maintains its listing on the OTC Markets under the ticker MOTS. As of December 4, 2025, the market capitalization was reported at $719.09.

Here's a quick look at the current public market valuation context:

Staffing has been reduced to the absolute minimum required for winding down. As of November 2025, the operational command structure is fundamentally simplified, steered by one individual whose mandate is strictly the orderly cessation of business operations and legal compliance.

• Key Personnel: Jeff Varsalone, listed as Sole Director and President.
• Staff Count: Reduced to a minimal administrative focus.
• Prior Employee Base: One report indicated a prior staff of 30 employees, which is now drastically lower.

Finally, the necessary administrative and legal infrastructure constitutes a key resource for the dissolution phase. This includes all the formal paperwork required to formally close the entity.

• Documentation Focus: Legal and accounting documentation for the dissolution process.
• Filing Status: The company was classified as a Non-accelerated filer and Smaller reporting company as of May 7, 2024, indicating minimal recent reporting requirements.
• Intellectual Property: The core IP for the Pure-Vu System is now held by CONMED Corporation, meaning Motus GI Holdings, Inc. retains only residual or administrative IP assets, if any.

Finance: draft 13-week cash view by Friday.

Motus GI Holdings, Inc. (MOTS) - Canvas Business Model: Value Propositions

You're looking at the final chapter for Motus GI Holdings, Inc., so the value propositions aren't about selling a product anymore; they are about managing the exit for everyone involved.

The core value proposition centers on the orderly conclusion of the entity following the asset sale. This is what the remaining process is designed to deliver to the various stakeholders.

• Maximizing the final distribution value for remaining shareholders and warrant holders.
• Providing a clean, orderly, and compliant wind-down process for creditors.
• Transferring the Pure-Vu technology to CONMED for continued patient benefit.
• Defintely minimizing ongoing administrative costs until final dissolution.

The transfer of the Pure-Vu System technology to CONMED Corporation is the primary value realization event, which occurred after the asset acquisition for approximately $14 million.

Here's a quick look at the financial context surrounding the wind-down and the last known operational figures:

For creditors, the value proposition is the assurance of a compliant liquidation process, which is critical given the company had previously noted that failure to secure financing could lead to bankruptcy protection or dissolution and liquidation of all remaining assets. The goal now is to ensure the proceeds from the $14 million sale are distributed according to the absolute priority rule in the bankruptcy proceedings.

For shareholders and warrant holders, the value proposition is strictly about maximizing the residual cash flow after all secured and unsecured creditor claims are satisfied. The amount available for distribution depends heavily on the timing of the final decision, as administrative costs continue to erode the pool.

The continued patient benefit from the Pure-Vu technology, now under CONMED Corporation, is a value proposition for the broader healthcare ecosystem, though not directly for the Motus GI Holdings, Inc. estate itself. CONMED's projected total 2025 revenue is between $1.365 billion and $1.372 billion, showing the scale under which the technology now operates.

Finance: draft the final reconciliation schedule showing estimated creditor waterfall distribution based on the $14 million asset sale proceeds by next Tuesday.

Motus GI Holdings, Inc. (MOTS) - Canvas Business Model: Customer Relationships

You're looking at the customer relationships for Motus GI Holdings, Inc. (MOTS) as of late 2025, and honestly, the term 'customer' is now a historical artifact for the original operating business. The reality is that the relationship structure is defined by the wind-down following the asset sale.

Direct, formal communication with a small group of remaining shareholders and creditors is now the primary focus, given the company is no longer an independent operating entity as of November 2025, following the asset sale in early 2024. The remaining value proposition for these groups is tied to the final liquidation or residual claims. The public trading status reflects this, with the stock price at $0.0001 as of December 4, 2025, on the OTC: MOTS market.

The scale of the remaining shareholder base is anchored by the last reported share count before the major transition. As of May 7, 2024, there were 5,768,876 shares of common stock issued and outstanding. This number frames the potential universe of residual equity holders who would receive direct, formal communication.

Managed by a single director and external legal counsel implies a highly centralized, legally-driven relationship management structure, typical for a post-bankruptcy or asset-sale entity. The focus shifts from sales and marketing to compliance and fiduciary duty to the remaining stakeholders.

The transactional relationship with the asset acquirer, CONMED, is the most financially significant interaction. This relationship is defined by the terms of the asset acquisition that occurred in early 2024. The Pure-Vu System technology was sold for approximately $14 million.

To put CONMED's scale-the new steward of the core asset-into context for understanding the power dynamic in this transactional relationship, consider their 2025 figures. CONMED reported Q3 2025 sales of $337.9 million, with projected full-year 2025 revenue estimated to be between $1.365 billion and $1.378 billion.

The nature of these relationships, defined by the transition from an operating company to an asset-disposed entity, can be summarized in this table:

Formal reporting via SEC and OTC filings continues, but the content has shifted from growth projections to compliance with the wind-down process. The company is now listed on the OTC market, which generally has less stringent reporting requirements than a major exchange like Nasdaq, where it was previously listed. The last reported EPS for the former entity was $-4.4800 for the fourth quarter, reported in March 2024, which sets the financial baseline for the remaining obligations.

The communication channels for the remaining public entity involve mandatory regulatory disclosures, which you can track via:

• SEC EDGAR Filings for the entity formerly known as MOTS.
• OTC Market regulatory updates.
• Formal notices regarding the status of creditors and residual claims.

Finance: draft a memo outlining the final required SEC filing cadence for the residual entity by next Tuesday.

Motus GI Holdings, Inc. (MOTS) - Canvas Business Model: Channels

You're looking at the channels Motus GI Holdings, Inc. (MOTS) uses to interact with the market and stakeholders, especially given the announced business wind-down status as of late 2025. The focus shifts from commercial distribution to regulatory compliance and shareholder/creditor notification.

Over-the-Counter (OTC) market for the remaining stock trading

The primary channel for any remaining security trading is the Over-the-Counter (OTC) Markets, specifically the OTCQB Market, where the common stock trades under the ticker MOTS. Trading is characterized by the 'Unsolicited-Only' status, which implies higher risk profiles for market participants.

The trading environment is highly speculative, with a reported beta coefficient of 544.08.

Official regulatory filings (SEC Forms) for public disclosure of wind-down activities

Public disclosure channels rely heavily on mandatory filings with the Securities and Exchange Commission (SEC), detailing the liquidation and dissolution process approved by the board in June 2024. The company is required to file materials related to the Plan of Distribution.

• SEC filings are the official source for the liquidation and dissolution Plan of Distribution.
• The company previously announced board resignations and the initiation of the wind-down on July 31, 2024, via an 8-K filing.
• Trailing Twelve Month (TTM) Earnings Per Share (EPS) was reported as -5.58 as of December 4, 2025.
• The last reported quarterly revenue estimate was 150.00K (for Q1 2024).
• The common stock par value is listed as $0.0001 per share.

Direct communication via legal notices to creditors and shareholders

Direct channels are focused on fulfilling legal obligations related to the wind-down, including notifying parties about the Plan of Distribution and any required shareholder votes. The company's telephone number for inquiries is listed as (954) 541-8000.

Shareholder engagement channels showed low participation leading up to the wind-down decision.

• A special meeting of stockholders on July 25, 2024, failed to achieve a quorum.
• Only approximately 28.16% of the shares outstanding were represented at that meeting.
• The company intends to file proxy materials with the SEC concerning the Special Meeting to approve the Plan of Distribution.

Motus GI Holdings, Inc. (MOTS) - Canvas Business Model: Customer Segments

You're looking at the final configuration of the Motus GI Holdings, Inc. (MOTS) ecosystem as of late 2025. Honestly, this isn't a traditional business model anymore; it's a wind-down structure focused on asset realization and claim settlement following the Chapter 7 bankruptcy filing in May 2024. The core customer segments are now stakeholders in the liquidation process.

Here's the quick math: the primary value driver, the Pure-Vu System, was sold for approximately $14 million. This transaction fundamentally redefined who the company serves now. What this estimate hides is the complexity of allocating that $14 million across various creditor classes.

Stakeholders in the Wind-Down

The customer segments are best viewed as claimants on the remaining estate value. These groups are focused on recovery, not product adoption.

• Remaining public shareholders holding the MOTS stock.
• Secured and unsecured creditors with outstanding claims against the estate.
• The single director and legal team managing the wind-down.
• CONMED Corporation, the buyer of the core Pure-Vu asset.

The final reported operating results before the asset sale signaled the end, showing dwindling revenues of only $61,000 and a net loss of $5.1 million. That context is key to understanding the current segments.

Remaining Public Shareholders Holding the MOTS Stock

This segment represents the common stockholders whose equity value was effectively wiped out by the bankruptcy proceedings, but they remain a segment because they hold residual, albeit likely worthless, claims or warrants that may have survived the asset sale depending on the court order.

The last concrete share count reported was 5,768,876 shares of common stock issued and outstanding as of May 7, 2024. Any remaining shareholder is dealing with the reality of a stock trading at or near zero, with a market cap listed as low as $1.28K in some late-stage data feeds, reflecting the shell status.

Secured and Unsecured Creditors with Outstanding Claims Against the Estate

These are the parties owed money by the former Motus GI Holdings, Inc. Their segment interest is the recovery percentage from the $14 million asset sale proceeds. Secured creditors take priority over unsecured creditors.

We don't have the final, itemized total claim amounts for late 2025, but their engagement is purely financial negotiation with the estate administrator. Their collective claim value dictates the distribution waterfall.

The Single Director and Legal Team Managing the Wind-Down

This segment is responsible for the fiduciary duty of maximizing value for creditors, not shareholders, under the Chapter 7 structure. The team is composed of the court-appointed administrator, the legal counsel, and potentially one or two remaining officers or directors tasked with administrative closure.

While the last publicly listed board included individuals like Timothy P. Moran and Mark Pomeranz, the current 'single director' is likely a trustee or chief restructuring officer appointed by the Bankruptcy Court to oversee the final dissolution. Their success metric is the efficient settlement of liabilities.

• Role: Fiduciary duty to creditors.
• Focus: Finalizing asset sale accounting.
• Key Action: Distributing net proceeds after administrative costs.

CONMED Corporation, the Buyer of the Core Pure-Vu Asset

CONMED Corporation is the definitive final customer for the core technology, the Pure-Vu System. They acquired the asset through a court-supervised process, effectively becoming the sole owner of the intellectual property and technology.

The transaction value was approximately $14 million. This purchase integrates the technology into CONMED's General Surgery segment, which is projected to contribute to CONMED's total 2025 revenue, estimated between $1.356 billion and $1.378 billion. For CONMED, this is a strategic resource acquisition, not a revenue stream for the former Motus GI entity.

Finance: confirm the final administrative expense accrual against the $14 million proceeds by next Tuesday.

Motus GI Holdings, Inc. (MOTS) - Canvas Business Model: Cost Structure

You're looking at the cost structure for Motus GI Holdings, Inc. (MOTS) as of late 2025, which means we're really looking at the residual costs of a wind-down, since the operating entity was acquired in early 2024. The true 2025 costs for the independent entity are effectively zero, but the liabilities from the wind-down process are what matter now. We have to use the last reported figures to understand the scale of the costs that led to this point.

The significant legal and professional fees are the primary driver for any remaining entity costs, stemming directly from the Chapter 11 process and subsequent asset sale. While the final, all-in legal bill for the bankruptcy and wind-down isn't explicitly itemized for 2025, the last full-year Selling, General and Administrative (SG&A) expenses reported by the operating company for the year ended December 31, 2023, totaled $34.0 million. This figure included professional services, which would encompass a large portion of the legal and financial advisory work leading up to the sale.

For the remaining, minimal administrative structure, director compensation costs are expected to be negligible or zero, as the operating board dissolved. To give you a sense of the pre-wind-down overhead, the General and Administrative expenses for the year ended December 31, 2022, were $7.6 million. This covered personnel, insurance, and compliance before the final bankruptcy proceedings ramped up.

Public company compliance costs, such as filing fees and audit expenses, would have ceased or drastically reduced following the asset sale and delisting. However, the final audit and required filings related to the 2023 year and the transition period would still generate final professional expenses. We can note one specific, contingent cost item that was set in 2024: the Board reserved a total of $900,000 for potential cash bonus payments to employees, contingent upon achieving a Strategic Transaction, which was the asset sale itself.

Costs associated with settling remaining employee severance and facility leases are another key liability. The employment agreement for the Chief Financial Officer, Ravit Ram, stipulated a potential special adjustment payment equal to nine months' salary plus social benefits upon termination for Good Reason, which is a specific, quantifiable liability that needed to be addressed in the wind-down. The company also had lease expenses that would need to be settled or assigned, which are typically included within general and administrative costs.

Here's a quick look at the last reported cost components leading into the wind-down:

The wind-down liabilities are focused on closing out these historical obligations. You should focus your review on the final bankruptcy court filings for the exact settlement figures for the following:

• Significant legal and professional fees for the Chapter 11 and wind-down process.
• Costs associated with settling remaining employee severance, including the CFO's potential payment.
• Costs associated with settling remaining facility leases.
• Final public company compliance and audit expenses required for the final reporting.

Finance: draft 13-week cash view by Friday.

Motus GI Holdings, Inc. (MOTS) - Canvas Business Model: Revenue Streams

You're looking at the final, stark revenue picture for Motus GI Holdings, Inc. before its independent operations concluded. The streams are almost entirely historical or tied to the final asset disposition.

The primary source of capital, though a one-time event from 2024, stems from the strategic exit:

• Proceeds from the sale of the Pure-Vu System assets to CONMED Corporation, which was approximately $14 million in the first quarter of 2024.

The residual, final operational revenue streams are detailed below. Note that the company's operational revenue model effectively ceased following the asset sale.

The old model, reliant on consumables, is confirmed to be obsolete for the entity Motus GI Holdings, Inc. as an independent operator:

• The old revenue from disposable sleeves (Q1 2024 was only $64,000) is now gone.

To be fair, that Q1 2024 sleeve revenue of $64,000 was the last gasp of the razor-and-blade component of the business model before the Chapter 7 filing and asset sale.

The structure of the final capital event is key to understanding the current financial state, which is now tied to the proceeds of that transaction:

• The asset sale to CONMED Corporation for approximately $14 million in Q1 2024 provided the main source of current capital.
• The cash and cash equivalents balance as of March 31, 2024, was $4.9 million.
• Net cash used in operating activities for the three months ended March 31, 2024, was $2.0 million.

Finance: draft 13-week cash view by Friday.